InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The firm have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
How did INMD's recent EPS compare to expectations?
The most recent EPS for Inmode Ltd is $0.25, not beating expectations of $0.3.
How did Inmode Ltd INMD's revenue perform in the last quarter?
Inmode Ltd revenue for the last quarter is $0.25
What is the revenue estimate for Inmode Ltd?
According to 7 of Wall street analyst, the revenue estimate of Inmode Ltd range from $99.96M to $88.59M
What's the earning quality score for Inmode Ltd?
Inmode Ltd has a earning quality score of B+/45.952087. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Inmode Ltd report earnings?
Inmode Ltd next earnings report is expected in 2026-08-04
What are Inmode Ltd's expected earnings?
Inmode Ltd expected earnings is $81.8M, according to wall-street analysts.
Did Inmode Ltd beat earnings expectations?
Inmode Ltd recent earnings of $82.01M beat expectations.